# Minimally Invasive Surgery and rhTNK-tPA for Intracerebral Hemorrhage Evacuation

> **NCT06668441** · PHASE1 · COMPLETED · sponsor: **Beijing Tiantan Hospital** · enrollment: 12 (actual)

## Conditions studied

- Intracranial Hemorrhages
- Cerebrovascular Disorders
- Cerebral Hemorrhage
- Hemorrhage

## Interventions

- **DRUG:** Minimally invasive surgery plus low-dose rhTNK-tPA group
- **DRUG:** Minimally invasive surgery plus medium dose rhTNK-tPA group
- **DRUG:** Minimally invasive surgery plus high dose rhTNK-tPA group

## Key facts

- **NCT ID:** NCT06668441
- **Lead sponsor:** Beijing Tiantan Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-11-04
- **Primary completion:** 2025-01-27
- **Final completion:** 2025-01-27
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2025-03-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06668441

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06668441, "Minimally Invasive Surgery and rhTNK-tPA for Intracerebral Hemorrhage Evacuation". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06668441. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*